Methyl imidazo[1,5-a]pyridine-5-carboxylate, 95.0%, 500mg

3-AMINO-5-NITROINDAZOLE, 95%, 250mg

3-Oxetaneacetonitrile, 95%, 10g

2-Vinylpyrazine, 97.0%, 1g

o-Anisidine , >=98 %, for synthesis, 2.5 L, glass packaging

tert-butyl 3-(aminomethyl)-2H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carboxylate, 97%, 250mg

4-(5-Methyl-1H-tetrazol-1-yl)aniline, 95.0%, 5g

3-BROMO-4,5-DIMETHYLANILINE, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-chloro-4-hydroxyphenyl)propanoic acid, 98%, 10g

1-tert-Butoxycarbonyl-4-(cyclopropylamino)piperidine, 95.0%, 100mg

tert-Butyl 4-(aminomethyl)-2-methylpiperidine-1-carboxylate, 98%, 100mg

2,4,6-TRI(9H-CARBAZOL-9-YL)-1,3,5-TRIAZINE, 95%, 25g

Diethyl (S)-(-)-2-Isocyanatoglutarate>97.0%(GC)1g